APM
Avidity Partners Management Portfolio holdings
AUM
$499M
This Quarter Return
+7.12%
1 Year Return
+3.47%
3 Year Return
+181.12%
5 Year Return
+409%
10 Year Return
–
AUM
$3.58B
AUM Growth
+$3.58B
(+20%)
Cap. Flow
+$540M
Cap. Flow
% of AUM
15.07%
Top 10 Holdings %
Top 10 Hldgs %
34.78%
Holding
131
New
36
Increased
33
Reduced
15
Closed
37
Top Buys
| 1 |
Intuitive Surgical
ISRG
|
$103M |
| 2 |
Medtronic
MDT
|
$85.4M |
| 3 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$80.2M |
| 4 |
Nuvation Bio
NUVB
|
$78.6M |
| 5 |
AbbVie
ABBV
|
$78M |
Top Sells
| 1 |
Eli Lilly
LLY
|
$137M |
| 2 |
Quest Diagnostics
DGX
|
$94.4M |
| 3 |
BioMarin Pharmaceuticals
BMRN
|
$87.1M |
| 4 |
Organogenesis Holdings
ORGO
|
$73.9M |
| 5 |
CHNG
Change Healthcare Inc. Common Stock
CHNG
|
$57.5M |
Sector Composition
| 1 | Healthcare | 96.26% |
| 2 | Financials | 0.29% |
| 3 | Industrials | 0% |
| 4 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Neurocrine Biosciences
NBIX
$13.5B
| $50.7M | 1.4% |
521,400
+221,400
| +74% | +$21.5M |
|
27
BridgeBio Pharma
BBIO
$9.91B
| $50.2M | 1.39% |
+815,100
| New | +$50.2M |
|
|
CCXI
28
DELISTED
ChemoCentryx, Inc.
CCXI
| $48.2M | 1.33% |
940,800
+183,800
| +24% | +$9.42M |
|
|
XLRN
29
DELISTED
Acceleron Pharma Inc.
XLRN
| $43.8M | 1.21% |
322,800
+23,800
| +8% | +$3.23M |
|
|
TRIL
30
DELISTED
Trillium Therapeutics Inc.
TRIL
| $43.1M | 1.19% |
4,015,000
+829,800
| +26% | +$8.91M |
|
|
ABMD
31
DELISTED
Abiomed Inc
ABMD
| $42.2M | 1.17% |
+132,500
| New | +$42.2M |
|
32
Natera
NTRA
$23B
| $40.2M | 1.11% |
395,600
-84,200
| -18% | -$8.55M |
|
33
Shattuck Labs
STTK
$61.3M
| $38.9M | 1.07% |
1,330,385
+391,572
| +42% | +$11.4M |
|
34
Inovio Pharmaceuticals
INO
$144M
| $37.2M | 1.03% |
+4,004,391
| New | +$37.2M |
|
|
KDMN
35
DELISTED
Kadmon Holdings, Inc.
KDMN
| $37.1M | 1.03% |
9,544,200
-25,800
| -0.3% | -$100K |
|
36
Alphatec Holdings
ATEC
$2.35B
| $36.9M | 1.02% |
2,334,000
+483,127
| +26% | +$7.63M |
|
37
IDEAYA Biosciences
IDYA
$2.26B
| $34.6M | 0.96% |
+1,472,000
| New | +$34.6M |
|
38
Dynavax Technologies
DVAX
$1.19B
| $34.4M | 0.95% |
3,500,000
-500,000
| -13% | -$4.92M |
|
39
Cigna
CI
$80.2B
| $32.6M | 0.9% |
+135,000
| New | +$32.6M |
|
|
ORTX
40
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
| $31.3M | 0.87% |
+4,317,800
| New | +$31.3M |
|
41
Athira Pharma
ATHA
$15.5M
| $30.9M | 0.85% |
1,677,845
+633,972
| +61% | +$11.7M |
|
42
Aldeyra Therapeutics
ALDX
$350M
| $30.3M | 0.84% |
2,552,000
+1,117,000
| +78% | +$13.3M |
|
43
Cullinan Oncology
CGEM
$456M
| $29.5M | 0.81% |
+707,359
| New | +$29.5M |
|
|
HARP
44
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| $29.5M | 0.81% |
1,408,000
+623,000
| +79% | +$13M |
|
45
Adicet Bio
ACET
$60.8M
| $29.2M | 0.81% |
+2,230,000
| New | +$29.2M |
|
46
Sotera Health
SHC
$4.54B
| $29M | 0.8% |
1,161,000
+461,000
| +66% | +$11.5M |
|
|
47
Organogenesis Holdings
ORGO
$629M
| $26.7M | 0.74% |
1,463,403
-4,058,097
| -73% | -$73.9M |
|
|
BLU
48
DELISTED
BELLUS Health Inc.
BLU
| $26.1M | 0.72% |
6,797,400
+1,071,400
| +19% | +$4.11M |
|
49
Kiniksa Pharmaceuticals
KNSA
$2.63B
| $24.6M | 0.68% |
1,330,700
+365,400
| +38% | +$6.76M |
|
50
Sana Biotechnology
SANA
$759M
| $24.5M | 0.68% |
+732,321
| New | +$24.5M |
|